Adenosine Receptors as Neuroinflammation Modulators: Role of A


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
21 07 2020
Historique:
received: 03 07 2020
accepted: 17 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 6 3 2021
Statut: epublish

Résumé

The pathological condition of neuroinflammation is caused by the activation of the neuroimmune cells astrocytes and microglia. The autacoid adenosine seems to be an important neuromodulator in this condition. Its main receptors involved in the neuroinflammation modulation are A

Identifiants

pubmed: 32708189
pii: cells9071739
doi: 10.3390/cells9071739
pmc: PMC7409197
pii:
doi:

Substances chimiques

Adenosine A1 Receptor Agonists 0
Adenosine A2 Receptor Antagonists 0
Receptors, Purinergic P1 0
Triazines 0
Triazoles 0
ZM 241385 0
2-chloro-N(6)cyclopentyladenosine 37739-05-2
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cereb Cortex. 2017 Jan 1;27(1):718-730
pubmed: 26534909
J Ethnopharmacol. 2017 Jan 4;195:255-265
pubmed: 27864112
Biochim Biophys Acta. 2011 May;1808(5):1319-28
pubmed: 20550943
J Neurochem. 2011 Apr;117(1):100-11
pubmed: 21235574
Antioxid Redox Signal. 2018 Jun 20;28(18):1626-1651
pubmed: 28467722
Ann Transl Med. 2015 Jun;3(10):136
pubmed: 26207229
Sci Rep. 2019 Nov 20;9(1):17207
pubmed: 31748653
Sci Immunol. 2019 Oct 11;4(40):
pubmed: 31604844
Curr Pharm Des. 2019;25(26):2875-2891
pubmed: 31333103
FASEB J. 1995 Dec;9(15):1577-84
pubmed: 8529837
J Neuropathol Exp Neurol. 2007 May;66(5):363-71
pubmed: 17483693
J Neural Transm (Vienna). 2018 May;125(5):797-807
pubmed: 28676934
Curr Pharm Des. 2008;14(15):1490-9
pubmed: 18537672
J Med Chem. 2000 Jan 27;43(2):250-60
pubmed: 10649980
Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1443-6
pubmed: 18066802
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):776-86
pubmed: 26934133
Physiol Behav. 2018 Feb 1;184:135-142
pubmed: 29174913
Front Neurol. 2018 Jan 23;9:8
pubmed: 29410649
Front Psychiatry. 2014 Jun 13;5:67
pubmed: 24982640
Cell Death Differ. 2019 Jan;26(1):41-52
pubmed: 30341422
Acta Pharmacol Sin. 2002 Nov;23(11):974-80
pubmed: 12421472
Cell Physiol Biochem. 2017;41(6):2279-2288
pubmed: 28456793
J Neurosci. 2004 Feb 11;24(6):1521-9
pubmed: 14960625
Trends Pharmacol Sci. 2005 Oct;26(10):511-6
pubmed: 16125796
Cell Death Dis. 2011 Apr 07;2:e142
pubmed: 21472005
J Neurochem. 2019 Apr;149(2):211-230
pubmed: 30614535
Free Radic Res. 2014 Feb;48(2):119-28
pubmed: 24060108
J Neurochem. 2016 Dec;139(6):1019-1055
pubmed: 27365148
Purinergic Signal. 2005 Jun;1(2):111-34
pubmed: 18404497
Inflammopharmacology. 2018 Feb;26(1):285-290
pubmed: 28646347
Glia. 2014 Jan;62(1):122-32
pubmed: 24272707
J Neurochem. 2005 Nov;95(4):919-29
pubmed: 16092928
Neuroscience. 2009 Sep 15;162(4):959-71
pubmed: 19477238
Neuropharmacology. 2012 Mar;62(3):1527-43
pubmed: 21315743
J Neuroinflammation. 2013 Jan 30;10:16
pubmed: 23363775
Nat Med. 2017 Sep 8;23(9):1018-1027
pubmed: 28886007
Front Neurol. 2018 Sep 11;9:605
pubmed: 30254599
J Biol Chem. 2001 Apr 20;276(16):13153-9
pubmed: 11278357
Biochim Biophys Acta. 2011 May;1808(5):1380-99
pubmed: 21145878
Cancer Res. 2006 Sep 1;66(17):8550-7
pubmed: 16951167
J Neural Transm (Vienna). 2018 May;125(5):781-795
pubmed: 28534174
Immunology. 2018 Jun;154(2):204-219
pubmed: 29513402
Adv Ther. 2020 Jan;37(1):113-139
pubmed: 31782132
J Neural Transm (Vienna). 2018 May;125(5):749-750
pubmed: 29623427
Pharmacol Rep. 2017 Jun;69(3):409-418
pubmed: 28273500
Int J Mol Sci. 2014 Jan 28;15(2):2024-52
pubmed: 24477263
Stem Cell Res Ther. 2019 Jan 11;10(1):18
pubmed: 30635041

Auteurs

Aleix Martí Navia (A)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Diego Dal Ben (D)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Catia Lambertucci (C)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Andrea Spinaci (A)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Rosaria Volpini (R)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Inês Marques-Morgado (I)

Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028 Lisbon, Portugal.

Joana E Coelho (JE)

Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028 Lisbon, Portugal.

Luísa V Lopes (LV)

Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Universidade de Lisboa, 1649-028 Lisbon, Portugal.

Gabriella Marucci (G)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Michela Buccioni (M)

School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino (MC), Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH